2025 Clinical Trials Epilepsy Tincture 
SMPL
MAY 26, 2020
CBD industry will be worth $16 billion by 2025. So federal agencies have been slow to regulate the booming industry — leading to a deluge of tinctures, smoothies and lotions that trusted tests have shown contain no CBD at all. fast-tracked clinical trials of GW Pharmaceuticals’ 98 percent CBD drug, Epidiolex.
Cannabis Law Report
OCTOBER 17, 2019
Some of the potential health benefits associated with THC and CBD, with and without the high, respectively, include reducing chronic pain such as from migraines or cancer, alleviating anxiety, reducing inflammation, and helping treat conditions such as epilepsy, PTSD, and glaucoma. billion in 2025, according to Grandview Research.
Expert insights. Personalized for you.
40 
Let's personalize your content